» Articles » PMID: 25479727

Piperine Inhibits Proliferation of Human Osteosarcoma Cells Via G2/M Phase Arrest and Metastasis by Suppressing MMP-2/-9 Expression

Overview
Date 2014 Dec 7
PMID 25479727
Citations 50
Authors
Affiliations
Soon will be listed here.
Abstract

The piperidine alkaloid piperine, a major ingredient in black pepper, inhibits the growth and metastasis of cancer cells both in vivo and in vitro, although its mechanism of action is unclear. Furthermore, its anticancer activity against osteosarcoma cells has not been reported. In this study, we show that piperine inhibited the growth of HOS and U2OS cells in dose- and time-dependent manners but had a weaker effect on the growth of normal hFOB cells. Piperine inhibited osteosarcoma cell proliferation by causing G2/M phase cell cycle arrest associated with decreased expression of cyclin B1 and increased phosphorylation of Cyclin-dependent kinase-1(CDK1) and checkpoint kinase 2 (Chk2). In addition, piperine treatment inhibited phosphorylation of Akt and activated phosphorylation of c-Jun N-terminal kinase (c-JNK) and p38 mitogen-activated protein kinase (MAPK) in HOS and U2OS cells. Piperine induced colony formation in these two cell types. We proved that piperine could suppress the metastasis of osteosarcoma cells using scratch migration assays and Transwell chamber tests. Moreover, gelatin zymography showed that piperine inhibited the activity of matrix metalloproteinase (MMP)-2/-9 and increased the expression of tissue inhibitor of metalloproteinase (TIMP)-1/-2. Taken together, our results indicate that piperine inhibits proliferation, by inducing G2/M cell cycle arrest, and the migration and invasion of HOS and U2OS cells, via increased expression of TIMP-1/-2 and down-regulation of MMP-2/-9. These findings support further study of piperine as a promising therapeutic agent in the treatment of osteosarcoma.

Citing Articles

Piperine induces cellular stresses, apoptosis, and cytotoxicity via JNK signaling and has concentration-dependently additive or synergistic effects with sorafenib in hepatocellular carcinoma: an in-vitro study.

Sayilan Ozgun G, Ozgun E, Karabas T, Suer Gokmen S, Eskiocak S Naunyn Schmiedebergs Arch Pharmacol. 2024; .

PMID: 39708099 DOI: 10.1007/s00210-024-03725-0.


Harnessing the role of aberrant cell signaling pathways in glioblastoma multiforme: a prospect towards the targeted therapy.

Hasan S, Mahmud Z, Hossain M, Islam S Mol Biol Rep. 2024; 51(1):1069.

PMID: 39424705 DOI: 10.1007/s11033-024-09996-3.


Targeting Cancer Hallmarks Using Selected Food Bioactive Compounds: Potentials for Preventive and Therapeutic Strategies.

Talib W, Abed I, Raad D, Alomari R, Jamal A, Jabbar R Foods. 2024; 13(17).

PMID: 39272454 PMC: 11395675. DOI: 10.3390/foods13172687.


Molecular Aspects of Piperine in Signaling Pathways Associated with Inflammation in Head and Neck Cancer.

Gusson-Zanetoni J, Cardoso L, de Sousa S, de Melo Moreira Silva L, de Oliveira Martinho J, Henrique T Int J Mol Sci. 2024; 25(11).

PMID: 38891950 PMC: 11172343. DOI: 10.3390/ijms25115762.


Promising Approaches in Plant-Based Therapies for Thyroid Cancer: An Overview of In Vitro, In Vivo, and Clinical Trial Studies.

Kaczmarzyk I, Nowak-Perlak M, Wozniak M Int J Mol Sci. 2024; 25(8).

PMID: 38674046 PMC: 11050626. DOI: 10.3390/ijms25084463.